{"id":473682,"date":"2020-03-13T13:06:01","date_gmt":"2020-03-13T13:06:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=473682"},"modified":"2020-03-13T13:06:01","modified_gmt":"2020-03-13T13:06:01","slug":"biotech-stock-that-will-change-lives-curr-is-a-new-delivery-company-that-improves-efficiency-safety-and-patient-experience","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biotech-stock-that-will-change-lives-curr-is-a-new-delivery-company-that-improves-efficiency-safety-and-patient-experience_473682.html","title":{"rendered":"Biotech Stock that will change lives: CURR is a new Delivery Company that Improves Efficiency, Safety and Patient Experience"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1583786265.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Biotech Stock that will change lives: CURR is a new Delivery Company that Improves Efficiency, Safety and Patient Experience\" src=\"https:\/\/www.abnewswire.com\/uploads\/1583786265.png\" alt=\"Biotech Stock that will change lives: CURR is a new Delivery Company that Improves Efficiency, Safety and Patient Experience\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">CURE Pharmaceutical [OTCQB: CURR] and Canopy Growth to Produce Oral Thin Films<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><img decoding=\"async\" style=\"display: block; margin-left: auto; margin-right: auto;\" src=\"https:\/\/www.abnewswire.com\/uploads\/8512cc77fba49ee74178a9bfe510f690.png\" alt=\"\" \/><\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>CURE Pharmaceutical <\/span><span>(OTCQB: <\/span><span>CURR<\/span><span>), based in Oxnard, CA, is a vertically integrated delivery and development company committed to improving efficacy, safety, and patient experience through its proprietary dosage forms and delivery systems. <\/span><span>CURR<\/span><span> has an FDA- and DEA- registered, GMP manufacturing facility and is a pioneering developer of CUREform&trade;, a patented delivery platform. CUREform&trade; includes CUREfilm<\/span><span><span>&reg;<\/span><\/span><span>, one of the most advanced oral thin films on the market today; microCURE&trade;, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods&trade; a novel chewable delivery system.&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>CURR<\/strong><span><strong> names Canopy Rivers Chairman John K. Bell, FCA, FCPA, ICD.D to its board of directors.<\/strong> <br \/><\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Bell brings more than 40 years of experience to the company, most recently serving as chairman of the Canopy Rivers board of directors and former chairman of Canopy Growth&rsquo;s board of directors<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>CURR<\/span><span> offers combined technologies that provide opportunities for both immediate and controlled-release delivery of a wide range of active ingredients. <\/span><span>CURR<\/span><span> partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, with partnerships in the U.S.A, Canada, Israel, and other markets. The <\/span><span>CURR<\/span><span> company mission is to improve people&rsquo;s lives by redefining how medicines are delivered and experienced.<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>CURR Products Fall Into Two Categories: Nutraceuticals (dietary supplements) and Pharmaceutical <br \/><\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Nutraceuticals:<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>CUREfilm<\/span><span><span>&reg;<\/span><\/span><span>&nbsp;Sleep<\/span><span>&nbsp;is a daily dietary supplement that delivers a unique blend of five active ingredients with the CUREfilm<\/span><span><span>&reg;<\/span><\/span><span>&nbsp;platform to promote healthy sleep patterns. This product is launched in U.S. markets.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>CUREfilm<\/span><span><span>&reg;<\/span><\/span><span>&nbsp;D<\/span><span>&nbsp;is a high-potency dietary supplement that provides 50,000 IU of Vitamin D3&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>CUREfilm<\/span><span><span>&reg;<\/span><\/span><span>&nbsp;&beta;-Caryophyllene<\/span><span>&nbsp;is a dietary supplement that contains 30mg of &beta;-Caryophyllene, a powerful terpene known for its anti-inflammatory and analgesic properties.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>CUREfilm<\/span><span><span>&reg;<\/span><\/span><span>&nbsp;Blue<\/span><span>&nbsp;contains 50mg of Sildenafil delivered with the CUREfilm<\/span><span><span>&reg;<\/span><\/span><span>&nbsp;platform.<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>CURR Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery<\/span><\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>CURR<\/span><span>has signed a licensing and collaboration agreement with <\/span><span>Vanguard Scientific Systems, Inc.<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><br \/>Vanguard is a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE&rsquo;s patented extraction methods, providing customer confidence in choosing Vanguard&rsquo;s portfolio of extraction manufacturers<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The&nbsp;industry&nbsp;is poised&nbsp;to grow to $2.1 billion in 2020, a 700% increase from 2016. <\/span><span>CURR<\/span><span> is strategically positioned with multiple high value assets and extremely well-placed marketing partners to optimize the company&rsquo;s earnings potential in the growing fields of key supply and delivery solutions, including the multi-billion-dollar marketplace.&nbsp;&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For more information on CURE Pharmaceutical<\/span><span>(OTCQB: <\/span><span>CURR<\/span><span>) visit: <\/span><span><a rel=\"nofollow\" href=\"https:\/\/medium.com\/@smallcap\/cure-pharmaceutical-otcqb-curr-is-a-vertically-integrated-drug-delivery-and-development-company-7d618bfa298e\">https:\/\/medium.com\/@smallcap\/cure-pharmaceutical-otcqb-curr-is-a-vertically-integrated-drug-delivery-and-development-company-7d618bfa298e<\/a><\/span><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/curepharmaceutical.com_55224.html\" rel=\"nofollow\">Cure Pharmaceuticals, Inc.<\/a><br \/><strong>Contact Person:<\/strong> Media Relations<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=biotech-stock-that-will-change-lives-curr-is-a-new-delivery-company-that-improves-efficiency-safety-and-patient-experience\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> (805) 824-0410<br \/><strong>Address:<\/strong>1620 Beacon Place  <br \/><strong>City:<\/strong> Oxnard<br \/><strong>State:<\/strong> CA 93033<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.curepharmaceutical.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.curepharmaceutical.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.curepharmaceutical.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=biotech-stock-that-will-change-lives-curr-is-a-new-delivery-company-that-improves-efficiency-safety-and-patient-experience\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CURE Pharmaceutical [OTCQB: CURR] and Canopy Growth to Produce Oral Thin Films CURE Pharmaceutical (OTCQB: CURR), based in Oxnard, CA, is a vertically integrated delivery and development company committed to improving efficacy, safety, and patient experience through its proprietary dosage &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/biotech-stock-that-will-change-lives-curr-is-a-new-delivery-company-that-improves-efficiency-safety-and-patient-experience_473682.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[425,426,417,427,404],"tags":[],"class_list":["post-473682","post","type-post","status-publish","format-standard","hentry","category-Finance","category-Financial-Market","category-Marketing-Sales","category-Personal-Finance","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/473682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=473682"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/473682\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=473682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=473682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=473682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}